| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $22.3M | -20.5% |
| R&D Expense | $25.8M | +18.2% |
| SG&A Expense | $30.6M | +7.4% |
| Operating Income | -$55.2M | -28.4% |
| Interest Expense | $6.1M | -7.6% |
| Net Income | -$62.0M | -25.9% |
| EPS (Basic) | -$12.22 | +21.2% |
| EPS (Diluted) | -$12.22 | +21.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.3M | -53.6% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $2.2M | -57.9% |
| Inventory | $4.3M | +9.6% |
| Current Assets | $19.4M | -56.4% |
| Total Assets | $34.3M | -43.3% |
| Current Liabilities | $10.1M | -13.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | -30.2% |
| Capital Expenditures | $339K | -26.3% |
| Investing Cash Flow | $9.7M | -61.0% |
| Financing Cash Flow | $29.1M | +41.5% |
| Free Cash Flow | -$51.0M | -29.6% |
| Total Liabilities |
| $74.0M |
| +0.7% |
| Stockholders' Equity | -$39.7M | -207.3% |